Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer
NCT00813696
Interventional
Phase 3
Unknown status
GIP-1
The purpose of this study is to evaluate the impact of the addition of cisplatin to gemcitabine in the treatment of patients with inoperable advanced pancreatic cancer.
Apr 30,2002
All
18 Years
75 Years
18 Years
75 Years
400